SW:NYSESmurfit WestRock plc Analysis
Data as of 2026-03-10 - not real-time
$42.74
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Smurfit WestRock (SW) trades at $42.74, just above its calculated support of $40.13 and sits comfortably above the 20‑day SMA (47.07) and 50‑day SMA (43.91), signalling a bullish medium‑term trend despite a bearish MACD histogram and decreasing volume. The stock offers an attractive 4.3% dividend yield, but the payout ratio exceeds 120%, raising concerns about sustainability. Recent earnings disclosed a miss on EPS (reported $0.34 vs. $0.46 consensus) and the permanent closure of a paper machine in Quebec, adding short‑term pressure on profitability.
Fundamentally, SW shows modest revenue growth (0.5%), thin margins (gross 19%, operating 6%), and a high debt‑to‑equity ratio (~81%). However, forward earnings are projected to more than double (forward EPS $3.27 vs. trailing $1.33), compressing the forward P/E to ~13 and underpinning analyst consensus (strong‑buy) with a median 12‑month price target of $59.5, implying ~38% upside.
Fundamentally, SW shows modest revenue growth (0.5%), thin margins (gross 19%, operating 6%), and a high debt‑to‑equity ratio (~81%). However, forward earnings are projected to more than double (forward EPS $3.27 vs. trailing $1.33), compressing the forward P/E to ~13 and underpinning analyst consensus (strong‑buy) with a median 12‑month price target of $59.5, implying ~38% upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Q4 earnings miss and EPS below consensus
- High leverage and unsustainable dividend payout
- Bearish MACD signal and decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward EPS expected to more than double, forward P/E ~13
- Analyst consensus strong‑buy with $59.5 median target
- Bullish SMA alignment and underlying secular demand for packaging
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable global demand for paper‑based packaging
- High debt level requiring deleveraging
- Dividend yield attractive but payout ratio above 100%
Key Metrics & Analysis
Financial Health
Revenue Growth0.50%
Profit Margin2.24%
P/E Ratio32.1
ROE3.91%
ROA3.17%
Debt/Equity81.01
P/B Ratio1.2
Op. Cash Flow$3.4B
Free Cash Flow$1.5B
Technical Analysis
TrendBullish
RSI40.3
Support$40.13
Resistance$52.65
MA 20$47.07
MA 50$43.91
MA 200$42.50
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
Fair Value$12.86
Target Price$59.07
Upside/Downside38.21%
GradeOvervalued
TypeBlend
Dividend Yield4.30%
Risk Assessment
Beta1.16
Volatility50.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.